KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EBIT: 2012-2025

Historic EBIT for Precigen (PGEN) over the last 14 years, with Sep 2025 value amounting to -$34.5 million.

  • Precigen's EBIT fell 62.17% to -$34.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$117.4 million, marking a year-over-year increase of 16.61%. This contributed to the annual value of -$135.0 million for FY2024, which is 35.36% down from last year.
  • Per Precigen's latest filing, its EBIT stood at -$34.5 million for Q3 2025, which was down 8.55% from -$31.8 million recorded in Q2 2025.
  • In the past 5 years, Precigen's EBIT registered a high of -$7.6 million during Q3 2022, and its lowest value of -$60.8 million during Q2 2024.
  • Over the past 3 years, Precigen's median EBIT value was -$24.4 million (recorded in 2024), while the average stood at -$29.4 million.
  • Its EBIT has fluctuated over the past 5 years, first soared by 64.64% in 2022, then slumped by 188.07% in 2024.
  • Precigen's EBIT (Quarterly) stood at -$21.9 million in 2021, then rose by 0.34% to -$21.8 million in 2022, then slumped by 57.01% to -$34.2 million in 2023, then rose by 16.68% to -$28.5 million in 2024, then tumbled by 62.17% to -$34.5 million in 2025.
  • Its EBIT stands at -$34.5 million for Q3 2025, versus -$31.8 million for Q2 2025 and -$22.6 million for Q1 2025.